Healthcare provider profile · identity verified

Daniel E Paul, MD

Allopathic & Osteopathic Physicians|Internal Medicine · NEW BERN, NC · NPI 1841283462

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Daniel E Paul, MD received $158.85 in general payments during 2025 across 7 reported records.

Boston Scientific Corporation accounted for 28.7% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 120 claims for Trelegy Ellipta by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 34 claims for Ozempic by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$158.85

7 reported records · 5 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Boston Scientific Corporation	Unresolved — no canonical attribution shown	$45.57	28.7%	2	2025
GlaxoSmithKline, LLC.	Unresolved — no canonical attribution shown	$43.54	27.4%	2	2025
ANI Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$28.82	18.1%	1	2025
Masimo Corporation	Unresolved — no canonical attribution shown	$25.06	15.8%	1	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$15.86	10.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$158.85	7

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Intracept Normalized: intracept	Device	Boston Scientific Corporation	$45.57	2	2025
Source payment records 2025-04-18 · Boston Scientific Corporation · $20.14 · Open Payments source 2025-05-02 · Boston Scientific Corporation · $25.43 · Open Payments source
NUCALA Normalized: nucala	Biological	GlaxoSmithKline, LLC.	$43.54	2	2025
Source payment records 2025-04-23 · GlaxoSmithKline, LLC. · $18.98 · Open Payments source 2025-07-08 · GlaxoSmithKline, LLC. · $24.56 · Open Payments source
PURIFIED CORTROPHIN GEL Normalized: purified cortrophin gel	Drug	ANI Pharmaceuticals, Inc.	$28.82	1	2025
Source payment records 2025-10-29 · ANI Pharmaceuticals, Inc. · $28.82 · Open Payments source
SET and rainbow SET Normalized: set and rainbow set	Device	Masimo Corporation	$25.06	1	2025
Source payment records 2025-03-19 · Masimo Corporation · $25.06 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	TRELEGY ELLIPTA open payments reported associated product	CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369	Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row	120	22
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	34	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	636	150
Atorvastatin Calcium	Atorvastatin Calcium	506	120
Losartan Potassium	Losartan Potassium	444	92
Rosuvastatin Calcium	Rosuvastatin Calcium	372	91
Metoprolol Succinate	Metoprolol Succinate	365	74
Gabapentin	Gabapentin	334	66
Levothyroxine Sodium	Levothyroxine Sodium	332	77
Omeprazole	Omeprazole	313	75
Hydrochlorothiazide	Hydrochlorothiazide	291	55
Tramadol Hcl	Tramadol Hcl	237	60
Esomeprazole Magnesium	Esomeprazole Magnesium	232	51
Metformin Hcl Er	Metformin Hcl	223	48
Tizanidine Hcl	Tizanidine Hcl	213	62
Lisinopril	Lisinopril	206	51
Sertraline Hcl	Sertraline Hcl	200	48
Pantoprazole Sodium	Pantoprazole Sodium	178	44
Furosemide	Furosemide	176	50
Tamsulosin Hcl	Tamsulosin Hcl	165	49
Montelukast Sodium	Montelukast Sodium	156	32
Methylprednisolone	Methylprednisolone	155	114
Albuterol Sulfate Hfa	Albuterol Sulfate	154	43
Potassium Chloride	Potassium Chloride	147	29
Eliquis	Apixaban	144	27
Simvastatin	Simvastatin	143	38
Zolpidem Tartrate	Zolpidem Tartrate	129	28
Metformin Hcl	Metformin Hcl	128	27
Escitalopram Oxalate	Escitalopram Oxalate	123	25
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	120	22
Famotidine	Famotidine	119	30
Alprazolam	Alprazolam	117	22
Fluticasone Propionate	Fluticasone Propionate	115	37
Mirtazapine	Mirtazapine	113	24
Meloxicam	Meloxicam	112	24
Ondansetron Odt	Ondansetron	97	29
Trazodone Hcl	Trazodone Hcl	95	23
Carvedilol	Carvedilol	89	21
Celecoxib	Celecoxib	89	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	88	23
Doxycycline Hyclate	Doxycycline Hyclate	88	64
Farxiga	Dapagliflozin Propanediol	88	14
Lorazepam	Lorazepam	88	21
Pregabalin	Pregabalin	88	20
Duloxetine Hcl	Duloxetine Hcl	83	20
Clopidogrel	Clopidogrel Bisulfate	76	23
Metoprolol Tartrate	Metoprolol Tartrate	72	22
Clonazepam	Clonazepam	67	19
Jardiance	Empagliflozin	67	15
Olmesartan Medoxomil	Olmesartan Medoxomil	65	16
Venlafaxine Hcl Er	Venlafaxine Hcl	65	suppressed
Allopurinol	Allopurinol	61	15
Fluconazole	Fluconazole	61	22
Eszopiclone	Eszopiclone	60	14
Valsartan	Valsartan	60	14
Warfarin Sodium	Warfarin Sodium	58	11
Azithromycin	Azithromycin	56	50
Ondansetron Hcl	Ondansetron Hcl	56	suppressed
Linzess	Linaclotide	55	18
Paroxetine Hcl	Paroxetine Hcl	54	13
Fluoxetine Hcl	Fluoxetine Hcl	53	suppressed
Spironolactone	Spironolactone	52	13
Sucralfate	Sucralfate	51	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	50	37
Oxybutynin Chloride Er	Oxybutynin Chloride	50	suppressed
Donepezil Hcl	Donepezil Hcl	48	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	48	23
Januvia	Sitagliptin Phosphate	47	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	13
Synthroid	Levothyroxine Sodium	43	11
Glimepiride	Glimepiride	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	11
Oxybutynin Chloride	Oxybutynin Chloride	42	suppressed
Alendronate Sodium	Alendronate Sodium	41	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	37
Atenolol	Atenolol	41	11
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	41	suppressed
Ibuprofen	Ibuprofen	40	16
Topiramate	Topiramate	40	suppressed
Febuxostat	Febuxostat	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Promethazine Hcl	Promethazine Hcl	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	35	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	34	19
Diazepam	Diazepam	34	suppressed
Ozempic	Semaglutide	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	23
Oxycodone Hcl	Oxycodone Hcl	33	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	32	suppressed
Clonidine	Clonidine	32	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Colchicine	Colchicine	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	14
Ventolin Hfa	Albuterol Sulfate	29	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Aripiprazole	Aripiprazole	28	suppressed
Dovato	Dolutegravir Sodium/Lamivudine	28	suppressed
Modafinil	Modafinil	28	suppressed
Mounjaro	Tirzepatide	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	11
Prazosin Hcl	Prazosin Hcl	26	suppressed
Colesevelam Hcl	Colesevelam Hcl	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Lactulose	Lactulose	24	suppressed
Niacin Er	Niacin	24	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Tresiba Flextouch U-100	Insulin Degludec	24	suppressed
Levofloxacin	Levofloxacin	23	20
Meclizine Hcl	Meclizine Hcl	23	11
Memantine Hcl	Memantine Hcl	23	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	13
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Glipizide	Glipizide	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Flecainide Acetate	Flecainide Acetate	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Baclofen	Baclofen	18	suppressed
Dexlansoprazole Dr	Dexlansoprazole	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Piroxicam	Piroxicam	18	suppressed
Prednisone	Prednisone	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Oxcarbazepine	Oxcarbazepine	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Nabumetone	Nabumetone	16	suppressed
Nystatin	Nystatin	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Efavirenz-Emtric-Tenofov Disop	Efavirenz/Emtricit/Tenofovr Df	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Mupirocin	Mupirocin	15	13
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Ethosuximide	Ethosuximide	14	suppressed
Invokana	Canagliflozin	14	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Budesonide Dr	Budesonide	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Isentress	Raltegravir Potassium	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Torsemide	Torsemide	13	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	12	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Estradiol	Estradiol	12	suppressed
Frovatriptan Succinate	Frovatriptan Succinate	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Finasteride	Finasteride	11	suppressed
Gemtesa	Vibegron	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Mitigare	Colchicine	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$158.85 · 7 records	Boston Scientific Corporation	Intracept, NUCALA, PURIFIED CORTROPHIN GEL, SET and rainbow SET	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error